内容概况：我国的步进电机在二十世纪七十年代初开始起步，七十年代中期至八十年代中期为成品发展 阶段，新品种和高性能电机不断开发，为行业奠定了坚实基础。在永磁材料、半导体技术及计算机技术 持续进步的推动下，步进电机如今已在众多领域中实现广泛应用。作为全球最重要的工业制造基地之 一，中国拥有庞大且增长迅速的步进电机市场。近年来，伴随中国制造业的转型升级，市场对步进电机 的需求持续增加，同时国内消费者对产品品质与性能的要求也日益提升。在此背景下，中国政府通过制 定科技创新规划和技术标准化规范等一系列政策措施，积极支持并引导行业技术进步与健康发展。数据 显示，中国步进电机行业市场规模已从2016年的17.39亿元稳步增长至2024年的38.9亿元，年复合增长率 达到10.59%。展望未来，步进电机市场空间广阔，预计产业规模将进一步扩大，2025年市场规模有望 达到41.24亿元。 上市企业：江苏雷利（300660）、鼎智科技（920593）、鸣志电器（603728）、兆威机电（003021）、 三协电机（920100）、雷赛智能（002979）、宝钢股份（600019）、首钢股份（000959）、鞍钢股份 （00089 ...

Core Insights - The report emphasizes the strong growth potential in the electronic materials sector, driven by rapid advancements in downstream industries, continuous technological iterations, and the backdrop of domestic substitution [2][6][10] - The mechanical equipment industry is expected to benefit from structural technological growth, particularly in high-end manufacturing, with a focus on sectors like controlled nuclear fusion and humanoid robots [12][14][17] Electronic Materials Sector - The semiconductor materials market is projected to reach $67.5 billion in sales by 2024, with a year-on-year growth of 3.8%, and is expected to exceed $87 billion by 2029, reflecting a CAGR of 4.5% from 2024 to 2029 [7] - The PCB materials segment is experiencing a shift towards high-frequency and high-speed applications, with the global market for electronic resins and fabrics estimated at approximately $33.02 billion and $24.13 billion respectively in 2023 [8] - The OLED materials market is anticipated to grow significantly, with global sales expected to reach $2.44 billion in 2024 and $8.498 billion by 2031, representing a CAGR of 19.8% from 2025 to 2031 [9] Mechanical Equipment Sector - The controlled nuclear fusion sector is entering a phase of accelerated commercialization, with significant government support and technological breakthroughs expected to drive growth [13][17] - The liquid cooling market is set to expand rapidly due to increasing demands for AI computing power, with liquid cooling becoming essential for future AI servers and data centers [14][17] - The humanoid robot industry is transitioning into mass production, with several companies achieving order and delivery milestones, indicating a growing market for related components [15][17] Tourism and Social Services - Domestic tourism showed strong growth during the New Year holiday, with 142 million domestic trips taken, reflecting a 5.2% increase year-on-year, and total spending reaching approximately 84.79 billion yuan, up 6.3% [20][22] - The cross-border travel market is also experiencing significant growth, with a 28.6% increase in the number of people entering and exiting the country during the holiday period [23] Medical and Biological Sector - The brain-computer interface market is gaining traction, with companies like Neuralink planning large-scale production of devices by 2026, indicating a growing interest in this emerging field [26][28][30] - Domestic companies are making strides in the brain-computer interface space, with over 200 firms reported to be involved, highlighting the potential for significant advancements in this technology [29][30]

作为国家级专精特新"小巨人"企业，无锡市晶源微电子股份有限公司（以下简称"晶源微电子"）自2003年成立以来，始终专注于高性能模拟和数模混合集 成电路领域的深耕细作。如今，这家历经二十载发展的半导体企业正加速冲刺资本市场，在中信证券的专业辅导下稳步推进首次公开发行股票并上市工 作，朝着"中国领先的半导体集成电路设计企业"愿景持续迈进。 从技术实力与研发创新来讲，晶源微电子展现出国家级高新技术企业的硬核实力。公司拥有一支技术实力雄厚、经验丰富的研发团队，具备基于Bipolar、 CMOS、BiCMOS、BCD多工艺平台的产品设计能力，构建了完善的研发体系与创新机制。截至公开信息显示，公司累计拥有专利信息220条、商标信息 18条以及著作权信息2条，仅2025年就有多款发明专利获得授权，涵盖压控振荡电路、自适应信号锁存电路、高压静电防护结构等多个核心技术领域。这 些技术成果不仅彰显了公司的研发创新能力，更有效提升了产品的核心竞争力，助力公司在细分领域形成技术壁垒。同时，公司还建成了江苏省模拟集成 电路IP核工程技术研究中心、市级工业企业设计中心两大研发机构，先后荣获工信部CSIP"十年中国芯"优秀设计企业、全国优 ...

Core Viewpoint - The demand for high-end PCB products is significantly increasing due to the expansion of AI computing power, leading to a notable rise in PCB equipment demand [4]. Group 1: PCB Equipment Market Overview - The global PCB specialized equipment market is projected to reach $10.8 billion by 2029, with a CAGR of 8.7% from 2024 to 2029 [5]. - Key equipment segments in 2024 include drilling (21%), exposure (17%), inspection (15%), and electroplating (7%) [5]. - The demand for mechanical and laser drilling equipment is expected to coexist, with domestic manufacturers likely to capture high-end mechanical drilling equipment replacement demand [5]. Group 2: Specific Equipment Insights - In the exposure equipment sector, LDI equipment is a critical competitive area, with market share concentrated among leading companies [5]. - The electroplating equipment sector features diverse technological routes, with domestic firms holding an advantage in vertical continuous electroplating [5]. - The inspection field is becoming increasingly competitive, moving towards 3D and online capabilities [5]. Group 3: Emerging Trends and Innovations - The introduction of NVIDIA's Rubin architecture is expected to reshape the demand and landscape for drilling equipment and drill bits [6][7]. - The anticipated use of M9-grade copper-clad laminates in PCBs will significantly increase processing difficulty and costs, leading to a projected multi-fold increase in demand for AI PCB drill bits [7]. - The short-term market for tungsten-cobalt alloy-coated drill bits will remain dominant for processing M9 materials, while the commercialization of diamond drill bits is still pending [7].

Group 1 - High-temperature alloys are critical materials in aerospace engines, gas turbines, and nuclear power equipment, directly influencing thrust, efficiency, and lifespan of high-end equipment [2][3] - The high-temperature alloy industry in China is accelerating due to the "Two Aircraft Special Project," the mass production of the C919 aircraft, breakthroughs in gas turbine localization, and the "dual carbon" strategy [2][4] - Nickel-based alloys dominate the market, accounting for 80% of demand, with deformation alloys making up 75% of production by 2024 [3][21] Group 2 - The production of high-temperature alloys in China increased from 19,000 tons in 2017 to 49,000 tons in 2023, with a CAGR of 17.1%, while demand rose from 21,000 tons to 52,000 tons, with a CAGR of 16.8% [4][34] - By 2024, production is expected to reach 57,000 tons, with aerospace (55%) and power generation (20%) as the main demand sectors [4][34] - The annual average demand for high-temperature alloys is projected to exceed 56,500 tons from 2025 to 2030, driven by factors such as the replacement of aircraft engines and the localization of commercial aircraft [4][39] Group 3 - The global high-temperature alloy market is expected to exceed $30 billion by 2025, with China's market projected to reach 120 billion yuan, growing at over 15% annually [5] - Domestic production capacity is expected to exceed 60,000 tons by 2025, but there remains a 30% supply gap for high-end products [5][6] - The domestic localization rate is anticipated to rise from less than 40% in 2020 to about 65% by 2025, supported by policies under the 14th Five-Year Plan [5][6] Group 4 - The industry is characterized by a "technology-driven, strong players" dynamic, with an expected annual compound growth rate of 15% from 2025 to 2027 [6] - Leading companies are achieving breakthroughs in niche markets, with notable revenue growth reported by companies such as Western Superconducting and Steel Research [6][8] - The competitive landscape shows a high concentration in upstream and a diverse midstream, with major players in the upstream segment like Fushun Special Steel [5][6] Group 5 - High-temperature alloys are primarily used in aerospace, accounting for over 50% of total demand, and are critical for the performance of advanced aircraft engines [26][34] - The demand for high-temperature alloys in gas turbines is expected to exceed 151,000 tons from 2025 to 2030, driven by domestic and international power generation needs [40][44] - The military sector is also a significant driver, with domestic naval gas turbines reaching international standards, enhancing the capabilities of the People's Navy [62]

点击 最 下方 关注《材料汇》 ， 点击"❤"和" "并分享 添加 小编微信 ，寻 志同道合 的你 正文 先进制程的成本暴涨体现在设计和建厂两端： 制程从平面 FET 演进至 FinFET、Nanosheet 后，量子效应、测试验证难度激增，导致设计成本指数级上 升；5nm 工厂投资是 20nm 的 5 倍，中小企业已无力承担先进制程的资本开支。 图表清晰展示，随着关键尺寸微缩，设计成本从 65nm 的 2800 万美元飙升至 2nm 的 7.25 亿美元，建厂投入同步激增。 这背后意味着 行业集中度将向头部晶圆厂倾斜，而先进封装通过 "混合制程" 让中小企业无需依赖先进制程即可参与高端芯片设计，成为行业格局重构的 关键变量。 芯粒异构集成的核心是 "按需分配工艺" ——CPU 等核心部件用 3nm 先进制程，I/O、模拟电路用成熟制程，最大化性价比。 与单片集成相比，其优势集中在 "IP 复用""良率改善""缩短上市时间"： IP 复用避免重复设计，研发周期缩短 30% 以上；小芯片良率远高于大芯片，拆 分后整体良率叠加，实际生产成本大幅降低；独立验证机制减少试错成本，快速响应市场需求。 这背后是 芯片行业 ...

中国证监会于1月5日披露，湖南长步道光电科技股份有限公司（以下简称"长步道"）已正式启动向不特 定合格投资者公开发行股票并在北京证券交易所上市的辅导备案，辅导机构为中金公司。 自2010年成立以来，长步道始终聚焦于技术要求较高的工业镜头业务，持续推进技术研发与产品创新。 目前，公司产品已成功应用于新能源、半导体、光伏、显示面板、3C电子等多个高端制造领域，助力 相关行业实现自动化检测、精密测量与智能识别，为客户提供高性价比的国产化光学解决方案。 此次启动北交所上市辅导，标志着长步道在调整资本市场路径后，继续借助证券化步伐加速发展，有望 进一步强化研发投入、扩大生产规模，提升在工业镜头领域的国产替代能力与市场竞争力。 值得关注的是，长步道此前曾冲刺科创板。公司于2023年6月30日递交科创板上市申请并获受理，但在 未回复首轮问询的情况下，于同年12月19日主动撤回申请，上市进程终止。此次转战北交所，公司表示 主要系基于战略规划调整及业务发展的综合考量。 作为国内工业镜头领域的领先企业，长步道深耕行业十余年，已形成涵盖标准工业镜头（FA镜头）、 线扫镜头（LS镜头）、大靶面镜头、远心镜头、特种工业镜头等在内的完整 ...

北水抢筹大金融板块。中国平安(02318)、中国人寿(02628)、中金公司(03908)分别获净买入18.4亿、5.88亿港元、1.85亿港 元。消息面上，国金证券发布研报指出，2026年开门红高景气的延续是本轮保险行情持续的重要支撑。从负债端的展望 来看，存款搬家有望驱动新单与NBV双位数正增长，利差继续改善，分红险转型将助推行业市占率进一步提升。该行还 表示，建议继续重点关注春季躁动行情下低估值券商的补涨机会，强烈推荐估值及业绩错配程度较大的优质券商，建议 关注AH溢价率较高、有收并购主题的券商。 智通财经APP获悉，1月6日港股市场，北水成交净买入28.79亿港元，其中港股通(沪)成交净买入9.75亿港元，港股通(深) 成交净买入19.03亿港元。 北水净买入最多的个股是中国平安(02318)、阿里巴巴-W(09988)、中国人寿(02628)。北水净卖出最多的个股是中国移动 (00941)、腾讯(00700)、华虹半导体(01347)。 | 股票名称 | 买入额 | 卖出额 | 买卖总额 | | --- | --- | --- | --- | | | | | 净流入 | | 阿里巴巴-W HK 09 ...

日前，马斯克表示其脑机接口公司Neuralink将于2026年开始对脑机接口设备进行"大规模生产"。作 为生命科学与信息技术融合的前沿领域，脑机接口现在正处于政策支持加码、技术快速迭代、商业化 加速落地的关键阶段，相关技术预计将在2026年迈向商业化，并从医疗刚需向AI应用、机器人等多 领域渗透。《研报金选·行业》于2025年6月25日、8月11日、12月29日多次提示关注相关领域投资机 会，截至目前，代表公司如翔宇医疗累计涨幅超过130%、创新医疗涨幅超100%、三博脑科等上涨超 70%。 前言 券商研报信息复杂？机构调研数据过时？屡屡错失投资机会？那是你不会挖！想知道哪份研报有用？什 么时候该看？《研报金选》满足你！每日拆解热门产业链或核心公司，快市场一步的投研思维+严苛的 研报选择标准+几近偏执的超预期挖掘，游资私募都在用！ 【金选回顾】 ②AI浪潮驱动存储量价齐升，DRAM价格已飙涨171.8%！海外限制再收紧，国内晶圆厂加速"国产替 代"，这些设备厂商成核心受益标的； ③ 广东新政力挺险资入市，保险股迎"资产+负债"双击； ④ 央企巨头领投10亿押宝雷鸟创新，AI眼镜赛道引爆在即。 点击付费阅读，解 ...

Core Viewpoint - The article discusses the significant price reduction in medical consumables across China, driven by new policies aimed at addressing the issue of inflated prices, which is reshaping the competitive landscape of the pharmaceutical industry [4][6][10]. Policy Implementation - The current price governance features "full coverage and dynamic adjustment," with various regions implementing complementary policies to manage prices effectively [6][10]. - Ningxia's recent notification requires companies to confirm the national minimum effective price by January 28, 2026, targeting high-risk consumables [6]. - Jiangxi initiated a normalization of price linkage in November 2025, expanding management to all listed consumables, while Heilongjiang's policy covers all listed products [6][7]. Price Reduction Impact - Medical consumables are experiencing drastic price drops, with some products seeing reductions of over 97%, such as ultrasound endoscope water bags dropping from 4,400 yuan to 127.15 yuan [7]. - High-value consumables like coronary stents have decreased from an average of 13,000 yuan to around 700 yuan, a reduction exceeding 93% [7]. - The cumulative savings from the centralized procurement of coronary stents and artificial joints from 2020 to 2025 exceed 200 billion yuan and 150 billion yuan, respectively [8]. Industry Restructuring - The introduction of a "floor price" is accelerating the reshaping and transformation of the medical consumables industry, ending the previous model reliant on regional price differences [10]. - Companies that fail to adjust prices in a timely manner face suspension from listing, particularly affecting small and medium-sized manufacturers [10]. - The competitive landscape is shifting, with domestic brands outperforming foreign companies in procurement bids due to significantly lower pricing [10]. Market Regulation Mechanism - The new market regulation mechanism is characterized by "normalization and intelligence," allowing for real-time monitoring and automatic price comparisons across the country [11]. - The goal is to establish a unified national pricing system, enhancing transparency and efficiency in the industry [12]. - Companies are encouraged to adapt to a compliant and transparent market environment, focusing on cost control and increased R&D investment in high-value products [12]. Future Outlook - The ongoing price governance is seen as a necessary step towards high-quality development in the medical industry, balancing price control with innovation incentives [12]. - The industry is expected to transition towards a model that prioritizes innovation, quality, and patient value, moving away from rapid, unregulated growth [12].